Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use

被引：20

作者：

Scrijvers, D. ^{[1
]}

Roila, F. ^{[2
]}

机构：

[1] Ziekenhuis Antwerpen Middelheim, Dept Med Oncol, Antwerp, Belgium

[2] S Maria Hosp, Dept Med Oncol, Terni, Italy

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷

关键词：

DARBEPOETIN ALPHA; INTRAVENOUS IRON; ANEMIA; CHEMOTHERAPY; MULTICENTER; EFFICACY; SAFETY;

D O I：

10.1093/annonc/mdp161

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：159 / 161

页数：3

共 14 条

[1] Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial [J].

Auerbach, M ;

Ballard, H ;

Trout, JR ;

McIlwain, M ;

Ackerman, A ;

Bahrain, H ;

Balan, S ;

Barker, L ;

Rana, J .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1301-1307

[2] Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia [J].

Bastit, Laurent ;

Vandebroek, An ;

Altintas, Sevilay ;

Gaede, Bernd ;

Pinter, Tamas ;

Suto, Tamas S. ;

Mossman, Tony W. ;

Smith, Kay E. ;

Vansteenkiste, Johan F. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1611-1618

[3] Pure red-cell aplasia and epoetin therapy [J].

Bennett, CL ;

Luminari, S ;

Nissenson, AR ;

Tallman, MS ;

Klinge, SA ;

McWilliams, N ;

McKoy, JM ;

Kim, B ;

Lyons, EA ;

Trifilio, SM ;

Raisch, DW ;

Evens, AM ;

Kuzel, TM ;

Schumock, GT ;

Belknap, SM ;

Locatelli, F ;

Rossert, J ;

Casadevall, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1403-1408

[4] Erythropoietin or Darbepoetin for patients with cancer [J].

Bohlius, J. ;

Wilson, J. ;

Seidenfeld, J. ;

Piper, M. ;

Schwarzer, G. ;

Sandercock, J. ;

Trelle, S. ;

Weingart, O. ;

Bayliss, S. ;

Brunskill, S. ;

Djulbegovic, B. ;

Benett, C. L. ;

Langensiepen, S. ;

Hyde, C. ;

Engert, E. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03)

[5]

CARO JJ, 2002, CANCER, V94, P2793

[6] Chemotherapy-induced anemia in adults: Incidence and treatment [J].

Groopman, JE ;

Itri, LM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) :1616-1634

[7] Anaemia of cancer: Impact on patient fatigue and long-term outcome [J].

Harper, P ;

Littlewood, T .

ONCOLOGY, 2005, 69 :2-7

[8] The European Cancer Anaemia Survey (ECAS):: A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients [J].

Ludwig, H ;

Van Belle, S ;

Barrett-Lee, P ;

Birgegård, G ;

Bokemeyer, C ;

Gascón, P ;

Kosmidis, P ;

Krzakowski, M ;

Nortier, J ;

Olmi, P ;

Schneider, M ;

Schrijvers, D .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) :2293-2306

[9] Anaemia in cancer: pathophysiology and treatment [J].

Mercadante, S ;

Gebbia, V ;

Marrazzo, A ;

Filosto, S .

CANCER TREATMENT REVIEWS, 2000, 26 (04) :303-311

[10]

Nutritional anaemias, 1968, World Health Organ Tech Rep Ser, V405, P5

← 1 2 →